Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive November 1, 2012	Europe's Trust Gap For the second time in recent memory, a top European regulator leaves office abruptly and under a cloud of suspicion.
Pharmaceutical Executive April 1, 2012 Feam & Lagus	Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help.
Pharmaceutical Executive October 1, 2011	The Essential--and Effective--Bureaucrat Fernand Sauer, First Director General, European Medicines Agency, has witnessed the progressive sterilization of innovative research due to a trend toward ever-larger industry concentration.
Pharmaceutical Executive February 1, 2014	Will Europe's Regulatory Watchdog Come Of Age In 2014? The author looks at the growing pains of the European Medicine Agency as it faces key policy challenges of 2014.
Pharmaceutical Executive December 1, 2012 William Looney	The Puzzle Master: Dr. Guido Rasi Europe's chief regulator charts a strategy from many moving parts.
Pharmaceutical Executive November 1, 2014	EMA -- a Pioneer Permanently At Bay Agency's plan for reporting clinical trial data has sparked strong reactions from health campaigners, industry, and patients.
Chemistry World September 30, 2014	Transparency measures forced on pharma Previous misdemeanors are compelling the pharmaceutical industry to be more open with financial information and clinical data.
Pharmaceutical Executive December 1, 2010	The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator The European Medicines Agency is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs.
InternetNews July 27, 2004 Susan Kuchinskas	Microsoft Set with Day in Court An EU appeals court will hear its request to suspend penalties in its antitrust judgment against the software vendor.
Pharmaceutical Executive January 1, 2012	Here's to a Happier New Year? A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science.
Pharmaceutical Executive April 1, 2011	Dalli's Formula Fails the Efficacy Test EU leadership on pharma policy leaves many wondering of the right man is at the helm.
Pharmaceutical Executive June 1, 2012	Europe Responds to Medical Device 'Crisis' A recent medical device controversy in France has pushed European health ministers to agree on a crisis management program for the troubled sector.
Pharmaceutical Executive June 1, 2011	A Lack of Information Why has the EU still not managed to update its rules on information about medicines?
BusinessWeek January 26, 2004	Another Battle Over European Union Rules The European Commission put its credibility on the line on Jan. 13 when it asked the European Court of Justice to review the controversial November decision by European Union Finance Ministers not to punish France and Germany for breaking the EU's financial regulations.
Pharmaceutical Executive October 1, 2014	Eruptions on the Drug-Pricing Horizon in Europe An escalating political debate over pharma pricing and reimbursement nears the boiling point.
Chemistry World May 8, 2013 Phillip Broadwith	Clinical trial data release blocked by companies Two pharmaceutical companies have been granted injunctions to prevent the European Medicines Agency from releasing clinical trial data about their drugs.
Pharmaceutical Executive April 1, 2014	Whatever Happened To Faster Reimbursement For Generics In Europe? The plan to accelerate generic pricing and reimbursement has become another tragic European casualty.
Chemistry World June 26, 2012 Sarah Houlton	Roche rapped for side-effect reporting failure Roche has been rapped by the European Medicines Agency for failing to report a large number of potential drug side-effects. The UK's Medicines and Healthcare products Regulatory Agency identified deficiencies in the company's medicine safety reporting system.
BusinessWeek November 3, 2003 David Fairlamb	They're Changing The Face Of Europe Judges on the European Court of Justice have become major players in the drive for economic integration.
InternetNews June 8, 2004 Ryan Naraine	Microsoft's EU Appeal: 'Innovation Undermined' Redmond's quest to undo the EU's $613 million fine and penalties officially begins.
Pharmaceutical Executive June 1, 2014	Hopes High as EU Heads Into Leadership Change The principal drug industry associations in Europe launched a call in mid-May for "an integrated European industrial policy for the pharmaceuticals sector."
Fast Company John Paul Titlow	The EU Officially Reveals Its Plan To Reduce Silicon Valley's Power In Europe As part of its ongoing effort to reposition its economy, the European Union just formally unveiled plans to unify its fractured markets and take a more aggressive stance toward U.S. tech companies.
InternetNews June 25, 2004 Susan Kuchinskas	Microsoft Looks to Stay EU's Hand Redmond files a formal request to stay the EU order to unbundle Windows and Windows Media Player.
InternetNews May 26, 2011	Microsoft Appeals Massive EU Fine While a ruling on the outcome is months away, Microsoft's appeal this week of a massive fine by the European Commission is being eyed by other U.S. firms.
Fast Company Annelise McGough	Google Cites Free Nature Of Search In EU Antitrust Defense Google has been the subject of a formal antitrust investigation in the European Union since April, over charges that it unfairly displays its own shopping service more prominently than competitors in search results.
Pharmaceutical Executive March 1, 2012	The Italian's Job After his predecessor and countryman left the EMA in disgrace, Guido Rasi jumps in as executive director with great challenges ahead.
Food Processing April 2006 David Joy	Regulatory Issues: WTO Sides With U.S. on GM Crops What the World Trade Organization decided on biotech foods in the European Union, and what it means to American producers.
Parameters Autumn 2004 Alan W. Dowd	A Different Course? America and Europe in the 21st Century Understanding the changes and challenges within Europe could help Americans respond to the changes and challenges facing the transatlantic community.
InternetNews April 21, 2006 Ed Sutherland	Another Strike For Microsoft EU Defense A New York court's decision is the last slap for Microsoft as it prepares for next week's antitrust ruling appeal.
Chemistry World July 3, 2014 Andy Extance	EMA wrangles restrain trial data progress Tempers are being tested as the pharmaceutical industry's journey towards transparency on clinical trial data enters a critical phase.
Chemistry World October 8, 2014 Phillip Broadwith	EMA finalizes trial transparency rules The European Medicines Agency has finalized its policy for sharing data from clinical trials.
Chemistry World October 31, 2014 Ned Stafford	Plea for EU to act on GM from plant scientists 21 top European plant scientists have issued an open letter demanding that the EU take action to ensure that they and other scientists are able to pursue genetically modified plant research.
InternetNews June 3, 2004 Susan Kuchinskas	Microsoft Readies EU Appeal The company marshals its forces for its fight to reverse the European Commission's ruling that it abused its market dominance.
Fast Company David Lumb	Continuing Its Battle With Silicon Valley, The EU Will Probe How Ads Affect Search Results The EU commission is launching a separate investigation into how online platforms list search results and how they use customer data -- all as part of a general plan for a "unified digital market" announced last week.
Pharmaceutical Executive November 1, 2013 Jill Wechsler	Transparency Troubles for Pharma High prices, murky financial relations, and a reluctance to disclose clinical data undermine public trust in industry and the research enterprise.
Chemistry World July 10, 2012	Interview: EMA head Guido Rasi His five-year appointment comes during a period of dramatic change for the pharma industry, which is struggling with patent expirations for many of its biggest selling drugs and a paucity of new drugs coming through the pipeline to take their place.
Fast Company Rose Pastore	Google Strikes Back Against Europe's Antitrust Charges Google published a blog post on Thursday responding to the European Commission's claims that some of its practices are anti-competitive.
Chemistry World January 3, 2013 Sarah Houlton	2012 pharma industry roundup It may have been a relatively quiet year in terms of mergers and acquisitions, but the pharma industry nonetheless made plenty of headlines in 2012.
American Family Physician June 1, 2006 Bayard, Holt & Boroughs	Nonalcoholic Fatty Liver Disease Nonalcoholic fatty liver disease is a common condition associated with metabolic syndrome. It is the most common cause of elevated liver enzymes in U.S. adults, and is diagnosed after ruling out other causes of steatosis, particularly infectious hepatitis and alcohol abuse.
CRM December 2015 Leonard Klie	European Union Rejects U.S. Data Privacy Laws Sharing customer data across the pond will get harder
Chemistry World January 7, 2014 Angeli Mehta	Flu drug stockpile may be worthless The case for spending hundreds of millions of pounds stockpiling antivirals for use in a flu pandemic is based on 'judgement rather than on evidence of their effectiveness', according to a parliamentary committee.
Chemistry World August 21, 2015 Sa njay Kumar	Indian pharma under increased regulatory scrutiny A Europe-wide ban on hundreds of generic pharmaceutical formulations tested by Indian contract research firm GVK Biosciences comes into force today.
Pharmaceutical Executive November 1, 2011	Europe Tackles 'Advertising in Disguise' Fears The EC's latest proposals have thrown water on Europe's fiery Direct-to-Consumer advertising debate. But is it enough to keep the flames at bay?
Fast Company David Lumb	Europe Unveils Strategy To (Finally) Compete With U.S. Tech Titans After multiple lawsuits aimed at U.S. tech titans, the European Union is proposing a unified digital marketplace for companies in all 28 member states that would compete with the likes of Facebook and Google.